Unilens Vision Inc (UVIC) 6.4500 $UVIC
Unilens Expands Distribution of All C-Vue(R) Brands With Diversified Ophthalmics, Inc.
Marketwire - Tue Aug 19, 7:28AM CDT
Unilens Vision Inc. (OTCQB: UVIC), which develops, licenses, manufactures, distributes and markets specialty contact lenses, and Diversified Ophthalmics, Inc. today announced that Diversified has been named an authorized distributor throughout the United States for Unilens' entire C-Vue(R) family of disposable and C-Vue(R) Advanced Custom contact lens brands. The lenses are available for sale now through all thirteen Diversified Ophthalmic locations.
Unilens Vision Inc. Declares Quarterly Cash Dividend Of $0.045 Per Share
PR Newswire - Fri Aug 01, 11:18AM CDT
The Unilens Vision Inc. (OTC Markets Group OTCQB: UVIC) Board of Directors today declared the 32nd consecutive quarterly cash dividend, payable August 22, 2014 at $0.045 per common share to stockholders of record at the close of business on August 11, 2014.
Unilens Vision Inc. Reports Operating Results for Second Quarter of FY2014
Marketwire - Fri Feb 14, 7:28AM CST
Unilens Vision Inc. (OTCQB: UVIC), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the second quarter and first half of FY2014.
Unilens Vision Reports Third Quarter Operating Results
Marketwire - Wed May 15, 7:28AM CDT
Unilens Vision Inc. (OTCQB: UVIC) (TSX VENTURE: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the third quarter and first nine months of FY2013.
Unilens Modifies License Agreement With Bausch + Lomb - Grants Right To Use Next Generation Multifocal Technology
PR Newswire - Thu Apr 11, 8:00AM CDT
Unilens Vision Inc. (OTC Markets Group OTCQB: UVIC) (TSX Venture Exchange: UVI), through it's wholly owned subsidiary Unilens Vision Sciences Inc. today announced that the company and Bausch + Lomb have extended the parties' existing licensing agreement.
Unilens Vision Announces National Roll-Out of Disposable C-Vue(R) HydraVUE(TM) Multifocal Silicone Hydrogel Contact Lenses
Marketwire - Thu Feb 21, 12:44PM CST
Unilens Vision Inc. (OTCQB: UVIC) (TSX VENTURE: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today announced the launch of its new silicone hydrogel disposable C-Vue(R) HydraVUE(TM) Multifocal contact lens for monthly replacement. The new product continues to incorporate Unilens' highly developed, world-class patented Multifocal design technology in a silicone hydrogel material, which offers the benefit of higher oxygen transmissibility for better eye health.
Unilens Vision Reports Second Quarter Operating Results
Marketwire - Thu Feb 14, 7:28AM CST
Unilens Vision Inc. (OTCQB: UVIC) (TSX VENTURE: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the second quarter and first half of FY2013.
Unilens Expands Distribution of All C-Vue(R) Brands With Diversified Ophthalmics, Inc.
Marketwire - Tue Aug 19, 7:28AM CDT
Unilens Vision Inc. (OTCQB: UVIC), which develops, licenses, manufactures, distributes and markets specialty contact lenses, and Diversified Ophthalmics, Inc. today announced that Diversified has been named an authorized distributor throughout the United States for Unilens' entire C-Vue(R) family of disposable and C-Vue(R) Advanced Custom contact lens brands. The lenses are available for sale now through all thirteen Diversified Ophthalmic locations.
Unilens Vision Inc. Declares Quarterly Cash Dividend Of $0.045 Per Share
PR Newswire - Fri Aug 01, 11:18AM CDT
The Unilens Vision Inc. (OTC Markets Group OTCQB: UVIC) Board of Directors today declared the 32nd consecutive quarterly cash dividend, payable August 22, 2014 at $0.045 per common share to stockholders of record at the close of business on August 11, 2014.
Unilens Vision Inc. Reports Operating Results for Second Quarter of FY2014
Marketwire - Fri Feb 14, 7:28AM CST
Unilens Vision Inc. (OTCQB: UVIC), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the second quarter and first half of FY2014.
Unilens Vision Reports Third Quarter Operating Results
Marketwire - Wed May 15, 7:28AM CDT
Unilens Vision Inc. (OTCQB: UVIC) (TSX VENTURE: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the third quarter and first nine months of FY2013.
Unilens Modifies License Agreement With Bausch + Lomb - Grants Right To Use Next Generation Multifocal Technology
PR Newswire - Thu Apr 11, 8:00AM CDT
Unilens Vision Inc. (OTC Markets Group OTCQB: UVIC) (TSX Venture Exchange: UVI), through it's wholly owned subsidiary Unilens Vision Sciences Inc. today announced that the company and Bausch + Lomb have extended the parties' existing licensing agreement.
Unilens Vision Announces National Roll-Out of Disposable C-Vue(R) HydraVUE(TM) Multifocal Silicone Hydrogel Contact Lenses
Marketwire - Thu Feb 21, 12:44PM CST
Unilens Vision Inc. (OTCQB: UVIC) (TSX VENTURE: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today announced the launch of its new silicone hydrogel disposable C-Vue(R) HydraVUE(TM) Multifocal contact lens for monthly replacement. The new product continues to incorporate Unilens' highly developed, world-class patented Multifocal design technology in a silicone hydrogel material, which offers the benefit of higher oxygen transmissibility for better eye health.
Unilens Vision Reports Second Quarter Operating Results
Marketwire - Thu Feb 14, 7:28AM CST
Unilens Vision Inc. (OTCQB: UVIC) (TSX VENTURE: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the second quarter and first half of FY2013.
